A leading pharmaceutical manufacturer had recently obtained an indication for once daily use (OaD) for erectile dysfunction to supplement its original “as needed (PRN)” indication. With quantity limits (QLs) of 4 to 8 tablets existing on its and similar PRN products, a spillover effect resulted in an accidental blanket QL placed on the drug, even when appropriately prescribed for OaD use. Discover how Precision helped get the QLs reversed.